跳至主要内容
临床试验/NL-OMON20490
NL-OMON20490招募中不适用

Target attainment of ciprofloxacin as infection prophylaxis during chemotherapy-induced neutropenia in patients treated for haematological malignancies.

Amsterdam UMC - location Academic Medical Centre (AMC), University of Amsterdam0 个研究点目标入组 46 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
46

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Hospitalized adult patients (age = 18 years) receiving ciprofloxacin as infection prophylaxis as part of standard care prescribed by the treating physician.

排除标准

  • Four patient-groups will be excluded as they are known to exhibit altered pharmacokinetics of antibiotics: patients in the intensive care unit (ICU), all patients receiving renal replacement therapy (RRT), patients with cystic fibrosis (CF) and severely burned patients.

研究者

发起方
Amsterdam UMC - location Academic Medical Centre (AMC), University of Amsterdam

相似试验